{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:15:36Z","timestamp":1790705736134,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtm.2024.101376","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T02:41:10Z","timestamp":1731465670000},"page":"101376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2887-1943","authenticated-orcid":false,"given":"Jiten","family":"Doshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Staiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk H.","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Zabaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101376_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2024.101376_bib2","series-title":"Gene, Cell, & RNA therapy landscape Q2 2021 quarterly data report","first-page":"21","author":"Barrett","year":"2021"},{"key":"10.1016\/j.omtm.2024.101376_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107764","article-title":"Cellular pathways of recombinant adeno-associated virus production for gene therapy","volume":"49","author":"Sha","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omtm.2024.101376_bib4","first-page":"2","article-title":"Capacity analysis for viral vector manufacturing","volume":"17","author":"Rininger","year":"2019","journal-title":"Bioproc. Int."},{"key":"10.1016\/j.omtm.2024.101376_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/viro.1997.8597","article-title":"Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line","volume":"233","author":"Louis","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2024.101376_bib6","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/ncomms5767","article-title":"Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations","volume":"5","author":"Lin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101376_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00253-017-8670-1","article-title":"Molecular design for recombinant adeno-associated virus (rAAV) vector production","volume":"102","author":"Aponte-Ubillus","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101376_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.18609\/cgti.2019.175","article-title":"A Pedregal Cost modelling comparison of adherent multi-trays with suspension and fixed-bed bioreactors for the manufacturing of gene therapy products","volume":"5","author":"E Cameau","year":"2020","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omtm.2024.101376_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2022.116","article-title":"Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells","volume":"34","author":"Giles","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101376_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.omtm.2023.02.008","article-title":"AAV vector production: Troublesome host innate responses in another setting","volume":"28","author":"Wright","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101376_bib11","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus","volume":"72","author":"Xiao","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib12","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.gt.3300680","article-title":"Adeno-associated virus vectors can be efficiently produced without helper virus","volume":"5","author":"Matsushita","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2024.101376_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hum.2023.146","article-title":"A Novel Role for the Adenovirus L4 Region 22K and 33K Proteins in Adeno-Associated Virus Production","volume":"35","author":"Adsero","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101376_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300685","article-title":"Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector production","volume":"19","author":"Johari","year":"2024","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtm.2024.101376_bib15","first-page":"470","article-title":"The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs","volume":"6","author":"Pilder","year":"1986","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2024.101376_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JVI.01725-06","article-title":"Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export","volume":"81","author":"Woo","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/jvi.62.1.206-210.1988","article-title":"Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs","volume":"62","author":"Samulski","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0042-6822(89)90272-9","article-title":"Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA","volume":"168","author":"Janik","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2024.101376_bib19","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/jvi.65.11.5657-5662.1991","article-title":"Adenovirus virus-associated RNA and translation control","volume":"65","author":"Mathews","year":"1991","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib20","doi-asserted-by":"crossref","first-page":"17485","DOI":"10.1074\/jbc.M802300200","article-title":"Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase","volume":"283","author":"Wahid","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101376_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/pharmaceutics3030338","article-title":"Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses","volume":"3","author":"Machitani","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2024.101376_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.omtm.2023.01.002","article-title":"Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells","volume":"28","author":"Chung","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101376_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111499","article-title":"Proteomic Landscape of Adeno-Associated Virus (AAV)-Producing HEK293 Cells","volume":"22","author":"Strasser","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2024.101376_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00633-24","article-title":"Role of the membrane-associated accessory protein (MAAP) in adeno-associated virus (AAV) infection","volume":"98","author":"Aksu Kuz","year":"2024","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib25","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1038\/s41467-021-26485-4","article-title":"The membrane associated accessory protein is an adeno-associated viral egress factor","volume":"12","author":"Elmore","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101376_bib26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1006\/jmbi.1996.0283","article-title":"Transactivation of adenovirus E2-early promoter by E1A and E4 6\/7 in the context of viral chromosome","volume":"258","author":"Swaminathan","year":"1996","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtm.2024.101376_bib27","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1093\/nar\/14.22.9035","article-title":"The E4 promoter of adenovirus type 2 contains an E1A dependent cis-acting element","volume":"14","author":"Gilardi","year":"1986","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2024.101376_bib28","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1128\/jvi.63.8.3479-3488.1989","article-title":"Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor","volume":"63","author":"Chang","year":"1989","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/JVI.78.1.441-453.2004","article-title":"The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication","volume":"78","author":"Stracker","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/JVI.72.1.420-427.1998","article-title":"Role of the adenovirus DNA-binding protein in in\u00a0vitro adeno-associated virus DNA replication","volume":"72","author":"Ward","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib29","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1128\/JVI.74.23.11407-11412.2000","article-title":"A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity","volume":"74","author":"Cathomen","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib30","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1128\/JVI.79.22.14004-14016.2005","article-title":"Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex","volume":"79","author":"Liu","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib31","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.74.11.5168-5181.2000","article-title":"Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein","volume":"74","author":"Nevels","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib32","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1101\/gad.926401","article-title":"Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex","volume":"15","author":"Querido","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2024.101376_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nature00863","article-title":"Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex","volume":"418","author":"Stracker","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101376_bib34","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1074\/jbc.M610405200","article-title":"The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage","volume":"282","author":"Hart","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101376_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/jvi.50.1.202-212.1984","article-title":"Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis","volume":"50","author":"Babiss","year":"1984","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib36","first-page":"2552","article-title":"Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport","volume":"5","author":"Babiss","year":"1985","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2024.101376_bib47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/jvi.70.1.520-532.1996","article-title":"Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis","volume":"70","author":"Fisher","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib48","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/JVI.02312-06","article-title":"Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production","volume":"81","author":"Nayak","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib39","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1128\/JVI.78.23.12868-12876.2004","article-title":"Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis","volume":"78","author":"Lu","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/nar\/gkp1028","article-title":"Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair","volume":"38","author":"Aparicio","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2024.101376_bib41","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/JVI.80.3.1376-1384.2006","article-title":"Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production","volume":"80","author":"Aparicio","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib42","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1128\/JVI.79.15.9556-9565.2005","article-title":"Suppression of RNA interference by adenovirus virus-associated RNA","volume":"79","author":"Andersson","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48901-z","article-title":"AAV production in stable packaging cells requires expression of adenovirus 22\/33K protein to allow episomal amplification of integrated rep\/cap genes","volume":"13","author":"Su","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101376_bib49","doi-asserted-by":"crossref","first-page":"10474","DOI":"10.1128\/JVI.01463-12","article-title":"The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection","volume":"86","author":"Wu","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib50","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/JVI.02455-08","article-title":"Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression","volume":"83","author":"Morris","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib51","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1128\/JVI.00652-13","article-title":"The adenovirus L4-33K protein regulates both late gene expression patterns and viral DNA packaging","volume":"87","author":"Wu","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib44","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/nar\/gkw1145","article-title":"The adenovirus L4-22K protein regulates transcription and RNA splicing via a sequence-specific single-stranded RNA binding","volume":"45","author":"Lan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2024.101376_bib45","doi-asserted-by":"crossref","first-page":"101370","DOI":"10.1016\/j.omtm.2024.101370","article-title":"Characterization of the function of Adenovirus L4 gene products and their impact on AAV vector production","volume":"32","author":"Nie","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101376_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01459-23","article-title":"The Cajal body protein p80-coilin forms a complex with the adenovirus L4-22K protein and facilitates the nuclear export of adenovirus mRNA","volume":"14","author":"White","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.omtm.2024.101376_bib52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1128\/JVI.76.4.1904-1913.2002","article-title":"Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes","volume":"76","author":"Qiao","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib53","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1021\/acssynbio.2c00207","article-title":"Construction of an rAAV Producer Cell Line through Synthetic Biology","volume":"11","author":"Lee","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.omtm.2024.101376_bib54","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1128\/JVI.72.9.7144-7153.1998","article-title":"The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis","volume":"72","author":"Marcellus","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib55","doi-asserted-by":"crossref","first-page":"e3094","DOI":"10.1002\/jgm.3094","article-title":"Evaluation of life cycle defective adenovirus mutants for production of adeno-associated virus vectors","volume":"21","author":"Kruger-Haag","year":"2019","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2024.101376_bib56","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.ymthe.2022.05.007","article-title":"Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques","volume":"30","author":"Zabaleta","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101376_bib57","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nbt731","article-title":"Macrolide-based transgene control in mammalian cells and mice","volume":"20","author":"Weber","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101376_bib58","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/hum.2019.277","article-title":"A Novel Next-Generation Sequencing and Analysis Platform to Assess the Identity of Recombinant Adeno-Associated Viral Preparations from Viral DNA Extracts","volume":"31","author":"Guerin","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101376_bib59","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omtm.2018.02.002","article-title":"Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras","volume":"9","author":"Tai","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101376_bib60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymthe.2023.11.022","article-title":"Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2024.101376_bib61","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","article-title":"Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors","volume":"70","author":"Ferrari","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib62","doi-asserted-by":"crossref","first-page":"12936","DOI":"10.1128\/JVI.01523-07","article-title":"The Mre11\/Rad50\/Nbs1 complex limits adeno-associated virus transduction and replication","volume":"81","author":"Schwartz","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib63","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/jvi.70.10.7030-7038.1996","article-title":"Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted","volume":"70","author":"Zhou","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2024.101376_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.omtm.2022.12.009","article-title":"High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography","volume":"28","author":"Florea","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101376_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4939-9139-6_4","article-title":"Quantitative and Digital Droplet-Based AAV Genome Titration","volume":"1950","author":"Sanmiguel","year":"2019","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012400192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905012400192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T16:07:00Z","timestamp":1737648420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905012400192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S232905012400192X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101376","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101376"}}